DURHAM, N.C. & SAN FRANCISCO–(BUSINESS WIRE)–BlueMatrix, the global leader in capital markets content publishing technology, backed by Thoma Bravo, today announced a partnership with Perplexity to bring AI-enabled research and discovery to institutional investors using BlueMatrix’s governed, entitlement-aware framework. Read...
Read MoreNEW YORK, Jan. 13, 2026 /PRNewswire/ — Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (TASE: ORMP) (“Oramed”) and Lifeward Ltd. (NASDAQ: LFWD) (“Lifeward”) today announced the signing of binding agreements for a strategic transaction between Oramed, Lifeward and a certain accredited investor. The transaction includes the transfer to Lifeward of Oramed’s proprietary Protein Oral Drug POD™ delivery technology and Oramed obtaining 49.9% beneficial ownership interest in Lifeward upon the satisfaction of certain terms and conditions. Read more...
Read MoreCAPE CANAVERAL, FL – Forget gradual transitions. Axiom Space is hitting the gas pedal on its plans for a fully independent commercial space station, accelerating its timeline and signaling a major shift in the future of low Earth orbit (LEO). The Houston-based company revealed a revised assembly plan aiming for a functional, free-flying habitat by late 2025 – a move that dramatically reduces reliance on the aging International Space Station (ISS) and throws down the gauntlet in the burgeoning private space station race. Read...
Read MoreJan 13 (Reuters) – Construction tech firm EquipmentShare.com said on Tuesday it was targeting a valuation of up to $6.41 billion in its U.S. initial public offering, potentially setting the tone for a strong year of listings. Read...
Read MoreBOSTON & SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Tahoe Therapeutics and Alloy Therapeutics announced today that they are forming a jointly seeded new company focused on developing first-in-class antibody-drug conjugates (ADCs) for patients with hard-to-treat cancers. Read more...
Read More
